What is the Rutherford classification for peripheral arterial disease (PAD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Rutherford Classification for Peripheral Arterial Disease

The Rutherford classification is a clinical grading system that categorizes peripheral arterial disease (PAD) severity from 0 to 6 based on symptoms and physical examination findings, ranging from asymptomatic disease through chronic limb-threatening ischemia (CLTI) with tissue loss. 1, 2

Classification Structure

The Rutherford system divides PAD into three grades and seven categories based on clinical presentation:

Grade I: Asymptomatic and Mild Symptoms

  • Category 0: Asymptomatic—no hemodynamically significant occlusive disease 3
  • Category 1: Mild claudication 3
  • Category 2: Moderate claudication 4
  • Category 3: Severe claudication 4

Grade II: Chronic Limb-Threatening Ischemia (CLTI)

  • Category 4: Ischemic rest pain 4, 5

Grade III: Chronic Limb-Threatening Ischemia with Tissue Loss

  • Category 5: Minor tissue loss—non-healing ulcer, focal gangrene with diffuse pedal ischemia 2, 4
  • Category 6: Major tissue loss—extending above transmetatarsal level, functional foot no longer salvageable 2

Clinical Significance and Prognostic Value

Higher Rutherford categories directly correlate with worse clinical outcomes, making this classification a powerful predictive tool for risk stratification. 2

Reoperation Risk

  • Categories 3-6 show significantly increased reoperation rates (28.2%) compared to lower categories (10.3%), with the largest jump occurring between categories 2 and 3 (4.7% to 26.8%). 2

Amputation Risk

  • Categories 4-6 demonstrate dramatically higher amputation rates (31.9%) versus categories 0-3 (7.2%), with a particularly steep increase between categories 4 and 5 (19.0% to 37.6%). 2

Mortality Risk

  • Categories 4-6 carry significantly elevated mortality rates (22.6%) compared to categories 0-3 (7.2%). 2

Bleeding Risk

  • Patients with Rutherford category 5/6 ischemia have markedly higher HAS-BLED scores (mean 3.20), indicating increased major bleeding risk when prescribing antithrombotic therapy. 5

Diagnostic Integration

The Rutherford classification should be determined at initial presentation through history and physical examination, then confirmed with objective hemodynamic testing. 2, 4

Supporting Hemodynamic Measurements

  • Ankle-brachial index (ABI) ≤0.90 confirms PAD diagnosis 1, 4
  • For CLTI (categories 4-6), specific thresholds apply: ankle pressure <50 mmHg, toe pressure <30 mmHg, or transcutaneous oxygen pressure (TcPO₂) <30 mmHg 1
  • Toe-brachial index (TBI) <0.70 indicates abnormal perfusion, particularly useful when ABI is falsely elevated due to arterial calcification 1, 6

Anatomic Correlation

  • Intermittent claudication (categories 1-3) associates significantly with aortoiliac disease, while critical limb ischemia (categories 4-6) correlates with crural (below-knee) disease. 7

Treatment Implications

The Rutherford category directly determines treatment urgency and modality selection. 2

Categories 0-3 (Claudication)

  • Guideline-directed medical therapy with antiplatelet agents, statins, and cardiovascular risk factor optimization 1, 8
  • Supervised exercise training programs 1, 8
  • Revascularization reserved for severe functional impairment not responding to conservative management 8

Categories 4-6 (CLTI)

  • Urgent revascularization is mandatory to prevent limb loss 6, 2
  • Early intervention is warranted given the marked increase in adverse outcomes at these classification thresholds 2
  • Intensive surveillance with duplex ultrasound every 2-3 months post-intervention markedly improves limb-salvage rates 6

Critical Pitfalls to Avoid

  • Do not rely solely on Rutherford classification without objective hemodynamic testing—clinical assessment must be confirmed with ABI, TBI, or TcPO₂ measurements 1, 6
  • In diabetic patients or those with heavily calcified vessels, ABI may be falsely elevated (>1.40); use TBI and TcPO₂ for accurate assessment 1, 6
  • Recognize that the transition from category 2 to 3 and from category 4 to 5 represent critical thresholds where complication rates dramatically increase 2
  • Patients with category 5/6 disease require careful antithrombotic therapy selection given their elevated bleeding risk 5

References

3
Research

Overview of classification systems in peripheral artery disease.

Seminars in interventional radiology, 2014

5
Research

Bleeding Risk Profile in Patients With Symptomatic Peripheral Artery Disease.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2016

6
Guideline

Management of Failed Infrainguinal Revascularization with Absent Flow

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

7
Research

Atherosclerotic risk factors and segmental distribution in symptomatic peripheral artery disease.

Journal of vascular and interventional radiology : JVIR, 2009

8
Research

Peripheral artery disease.

Nature reviews. Disease primers, 2025

Related Questions

Is hypotension a typical feature of peripheral arterial disease (PAD)?
What is the optimal management for an 89-year-old female with severe peripheral arterial disease?
How should I write an order for a bilateral lower extremity arterial duplex ultrasound to evaluate for peripheral arterial disease?
How do peripheral arterial disease (PAD) and chronic limb ischemia (CLI) differ, and what are the recommended management strategies for each?
In an adult patient with intact skin, no peripheral vascular disease, and no infection at the donor site, what are the guidelines for harvesting fascia lata—including optimal location, maximum graft dimensions, and precautions to prevent complications such as lateral femoral cutaneous nerve injury, hematoma, seroma, wound dehiscence, and sensory loss?
What is thyroglobulin washout and what does it indicate clinically?
Is my low mood in the morning and lack of motivation to go to work a sign of worsening depression or a side effect of bupropion (Wellbutrin) that will improve over time?
What are the clinical indications for clonazepam?
Should I reduce the escitalopram dose or switch to another antidepressant because 15 mg causes persistent daytime drowsiness even when taken at night?
I am taking escitalopram 15 mg and bupropion XL 300 mg daily, but I feel low and sluggish in the mornings and don’t want to go to work; how can I adjust my medications to improve my morning energy?
What is the appropriate management for angina bullosa hemorrhagica?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.